| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |